Business Segments · Other segment items

Business Segments — Other segment items

Amgen Business Segments — Other segment items increased by 94.7% to -$87.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 84.8%, from -$573.00M to -$87.00M. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementSegment
CategoryOther
SignalLower is better
VolatilityVolatile
First reportedQ1 2024
Last reportedQ1 2026

How to read this metric

Frequent or large charges may indicate operational instability or significant restructuring efforts.

Detailed definition

Captures miscellaneous income or expense items that do not fit into standard functional categories like R&D or sales. Th...

Peer comparison

Commonly found as 'Other Operating Income/Expense' in financial statements.

Metric ID: amgn_segment_reportable_segment_other_segment_items

Historical Data

7 periods
 Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value$520.00M$445.00M-$1.66B-$573.00M$539.00M-$1.64B-$87.00M
QoQ Change-14.4%-473.3%+65.5%+194.1%-404.6%+94.7%
YoY Change-210.2%+21.1%+1.1%+84.8%
Range-$1.66B$539.00M
CAGR-69.6%
Avg YoY Growth-25.8%
Median YoY Growth+11.1%

Frequently Asked Questions

What is Amgen's business segments — other segment items?
Amgen (AMGN) reported business segments — other segment items of -$87.00M in Q1 2026.
How has Amgen's business segments — other segment items changed year-over-year?
Amgen's business segments — other segment items increased by 84.8% year-over-year, from -$573.00M to -$87.00M.
What does business segments — other segment items mean?
Non-recurring or miscellaneous financial items that affect the company's overall performance.